Skip to content
Center for Reproductive Rights
Center for Reproductive Rights

Primary Menu

  • About
    • Overview
    • The Center’s Impact
    • Center Leadership & Staff
    • Annual Reports
    • Corporate Engagement
    • Diversity, Equity and Inclusion
    • Careers
    • Contact Us
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • Cases Archive
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Global Advocacy
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
  • News
    • Latest News
    • Stories
    • Events
    • Center in the Spotlight
    • Press Releases
    • Statements
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • U.S. Abortion Rights: Resources
    • Maps
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
    • Repro Red Flags: Agency Watch
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Become a Monthly Donor
    • Make a Donor Advised Fund Gift
    • Leave a Legacy Gift
    • Donate Gifts of Stock
    • Give a Gift in Honor
    • Attend an Event
    • Employee Matching Gifts
    • Mail a Check
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
Donate
icon-hamburger icon-magnifying-glass Donate
icon-magnifying-glass-teal

Whole Woman’s Health Alliance v. FDA

Center for Reproductive Rights - Center for Reproductive Rights - search logo
search Close Close icon
Center for Reproductive Rights -
Menu Close Menu Close icon
Donate

Primary Menu

  • About
    • Overview
    • The Center’s Impact
    • Center Leadership & Staff
    • Annual Reports
    • Corporate Engagement
    • Diversity, Equity and Inclusion
    • Careers
    • Contact Us
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • Cases Archive
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Global Advocacy
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
  • News
    • Latest News
    • Stories
    • Events
    • Center in the Spotlight
    • Press Releases
    • Statements
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • U.S. Abortion Rights: Resources
    • Maps
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
    • Repro Red Flags: Agency Watch
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Become a Monthly Donor
    • Make a Donor Advised Fund Gift
    • Leave a Legacy Gift
    • Donate Gifts of Stock
    • Give a Gift in Honor
    • Attend an Event
    • Employee Matching Gifts
    • Mail a Check
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn

  • Overview

Share this page

Donate Now

Join Now

Whole Woman’s Health Alliance v. FDA

Filing date: 05.08.2023
This lawsuit seeks to eliminate U.S. Food and Drug Administration (FDA) restrictions that impede access to the abortion medication mifepristone.

Share this page

  • facebook
  • Twitter
  • linkedin
  • Email id

Case update: The Center and FDA have filed cross-motions for summary judgment that will be fully briefed on March 18, 2025. Oral argument was held May 19, 2025.


On May 8, 2023, the Center for Reproductive Rights filed a lawsuit in federal district court in Virginia that challenges the FDA’s Risk Evaluation and Mitigation Strategy (REMS) for the abortion medication mifepristone. Mifepristone, part of a two-pill regimen for medication abortion, was first approved in 2000.

Medication abortion is the most commonly used method of abortion in the United States, accounting for 63% of abortions in the country in 2023.

Brought on behalf of independent abortion providers in Virginia, Montana, and Kansas, the lawsuit seeks to eliminate the REMS—a unique set of restrictions that limit the number of providers who prescribe mifepristone and pharmacies that dispense it, and impede patient access to time-sensitive abortion care. 

The REMS requires:

  • Mifepristone prescribers to register with the drug manufacturer, thereby deterring some otherwise qualified providers from prescribing the medication because of the fear that registration could expose them to anti-abortion violence or harassment;
  • That pharmacies be specially certified in order to dispense mifepristone and that they maintain copious records; and 
  • Patients to review and sign a counseling form that is duplicative, inaccurate, and confusing, and can be distressing for patients taking mifepristone for miscarriage management because it mandates they acknowledge they “have decided to take mifepristone and misoprostol to end [their] pregnancy.”

The lawsuit argues that the FDA’s decision to maintain the REMS violates the federal Administrative Procedure Act because the FDA: 

  • Failed to make the determinations Congress directed it to make before subjecting a medication to a REMS. 
  • Refused to consider evidence that the REMS does not enhance patient safety and the argument that mifepristone is regulated far more restrictively than other drugs that pose similar or more serious risks.

The case, Whole Woman’s Health Alliance v. FDA, was filed in the Western District of Virginia, Charlottesville Division.

On August 21, 2023, the federal court denied the Center’s request for a preliminary injunction that would have barred the FDA from reinstating significant restrictions on mifepristone in Virginia, Montana and Kansas as the result of orders issued in a separate case. In its ruling in WWH v. FDA, the district court acknowledged the safety and importance of mifepristone.

The Center and the FDA have now filed cross-motions for summary judgment that will be fully briefed on March 18, 2025. Oral argument is scheduled for May 19, 2025.

Case Details

Plaintiff(s): Whole Woman’s Health clinics in Virginia; Blue Mountain Clinic in Montana; All Families Healthcare and Helen Weems in Montana; and Trust Women in Kansas

Respondent(s): Food & Drug Administration (FDA); Department of Health and Human Services (HHS)

Center Attorney(s): Linda Goldstein, Olivia Roat

Legal documents:

  • Defendants’ Reply in Support of Cross-Motion for Summary Judgment, 3.18.25
  • Reply to Cross-Motion for Summary Judgment, 02.04.25
  • Defendants’ Combined Memorandum in Support of Cross-Motion for Summary Judgment, 12.18.24
  • Memorandum of Law in Support of Plaintiffs’ Motion for Summary Judgment, 10.23.24
  • Ruling by the Western District of Virginia, Charlottesville Division, 08.21.23
  • Complaint for Declaratory and Injunctive Relief, 05.08.23

Case news:

  • Center Files Lawsuit to Ensure Access to Abortion Drug in Three States, 05.08.23
  • Press release: Abortion Providers Sue FDA to Protect Access to Abortion Pill, 05.08.23

Timeline

May 08, 2023 The Center files a lawsuit in federal district court in Virginia on behalf of independent abortion providers.
January 12, 2024 Case stayed pending the Supreme Court’s decision in another case against the FDA.
July 12, 2024 Court enters briefing schedule for summary judgment motions.
October 23, 2024 Plaintiffs file motion for summary judgment.
December 18, 2024 Defendants file cross-motion for summary judgment and opposition to the plaintiffs’ motion for summary judgment.
February 05, 2025 Plaintiffs file their reply in support of motion for summary judgment.
May 19, 2025 Oral argument held.
Get the latest news on reproductive rights and opportunities to take action.

Related Content

Issues:

Abortion, Legal Protections, Legal Restrictions

Regions:

United States

Work:

In the Courts

Case Status:

Open

Case Archive

For updates on Center cases, explore our case archive here.

Footer Menu

  • Careers
  • Privacy Policy
  • Gift Acceptance Policy
  • Contact Us

Center for Reproductive Rights
© (1992-2024)

Use of this site signifies agreement with our disclaimer and privacy policy.

Better Business Bureau Charity Watch Top Rated Center for Reproductive Rights
This site uses necessary, analytics and social media cookies to improve your experience and deliver targeted advertising. Click "Options" or click here to learn more and customize your cookie settings, otherwise please click "Accept" to proceed.
OPTIONSACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_UA-6619340-11 minuteNo description
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
_parsely_session30 minutesThis cookie is used to track the behavior of a user within the current session.
HotJar: _hjAbsoluteSessionInProgress30 minutesNo description
HotJar: _hjFirstSeen30 minutesNo description
HotJar: _hjid1 yearThis cookie is set by Hotjar. This cookie is set when the customer first lands on a page with the Hotjar script. It is used to persist the random user ID, unique to that site on the browser. This ensures that behavior in subsequent visits to the same site will be attributed to the same user ID.
HotJar: _hjIncludedInPageviewSample2 minutesNo description
HotJar: _hjIncludedInSessionSample2 minutesNo description
HotJar: _hjTLDTestsessionNo description
SSCVER1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for online advertising by creating user profile based on their preferences.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
_fbp3 monthsThis cookie is set by Facebook to deliver advertisement when they are on Facebook or a digital platform powered by Facebook advertising after visiting this website.
fr3 monthsThe cookie is set by Facebook to show relevant advertisments to the users and measure and improve the advertisements. The cookie also tracks the behavior of the user across the web on sites that have Facebook pixel or Facebook social plugin.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
IMRID1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for storing the start and end of the user session for nielsen statistics. It helps in consumer profiling for online advertising.
personalization_id2 yearsThis cookie is set by twitter.com. It is used integrate the sharing features of this social media. It also stores information about how the user uses the website for tracking and targeting.
TDID1 yearThe cookie is set by CloudFare service to store a unique ID to identify a returning users device which then is used for targeted advertising.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
adEdition1 dayNo description
akaas_MSNBC10 daysNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
geoEdition1 dayNo description
next-i18next1 yearNo description
SAVE & ACCEPT
Powered by CookieYes Logo
Scroll Up